Fermer le menu


Member of Lyonbiopole


NewClin develops a data-driven and AI-powered game-changing SaaS B2B platform to automatically contextualize patients' health data with their non-medical (social, behavioral, environmental) determinants of health. It allows the production of new patient-, cohort- and population-related predictive and prognostic markers, including a unique patient's Health Determinome, paving the way for precision interventions and precision prevention.

Our ambition is to transform decisions from industry, healthcare providers, researchers, and payors in order to decrease the cost and increase the performance or healthcare and clinical research and improve and/or prolong patients' lives.

Our current focus is oncology, but our solution is applicable to other therapeutic fields.


Strategic application domain: Medical Technologies

Application market: Oncology, Others

Type of activity: E-Health, Medical device

Technologies: AI, (Bio) Informatics & software, ICT for Health - Digital

Created on sept. 19th, 2019 - 3 employees



Chez PULSALYS 47, boulevard du 11 Novembre 1918 69100 Villeurbanne



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.